According to Coherus BioSciences 's latest financial reports and stock price the company's current number of shares outstanding is 97,738,509. At the end of 2023 the company had 97,738,509 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 97.73 M | 25.38% |
2022 | 77.95 M | 1.47% |
2021 | 76.82 M | 6.38% |
2020 | 72.22 M | 2.87% |
2019 | 70.2 M | 3.11% |
2018 | 68.08 M | 16.7% |
2017 | 58.34 M | 31.58% |
2016 | 44.34 M | 13.88% |
2015 | 38.93 M | 96.23% |
2014 | 19.84 M | 9.72% |
2013 | 18.08 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Amgen AMGN | 535,000,000 | 447.38% | ๐บ๐ธ USA |
Repligen
RGEN | 55,815,666 | -42.89% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | 1,242,000 | -98.73% | ๐บ๐ธ USA |
Arena Pharmaceuticals
ARNA | 56,662,000 | -42.03% | ๐บ๐ธ USA |